NexFlow Logo

Accurate, Personalized Diabetes Insights

The world's first real-time, AI-powered platform to detect and reverse insulin resistance—the earliest known predictor of Type 2 Diabetes.

The Problem

1 in 3
U.S. adults have prediabetes
98M+
Americans with prediabetes
541M
Adults globally with impaired glucose tolerance

Our Solution

NexFlow offers real-time insulin resistance monitoring through non-invasive methods, making early intervention accessible and affordable.

IRScore

A real-time, AI-generated score from 0 to 100 that quantifies your risk of insulin resistance. Simply input lifestyle and biomarker data and receive an easy-to-understand score that updates as new data is logged.

Trajectory Panel

Visualize how your IRScore evolves over time, helping you see the effects of specific habits. Track daily behaviors and biomarker updates to identify patterns, measure progress, and course-correct in real-time.

Recommendation System

Receive personalized, science-backed suggestions based on your lifestyle and biomarker data. Each tip includes a projected IRScore gain, helping you take clear, goal-driven action.

How It Works

Data Input Interface

Input Your Data

Log your lifestyle factors (sleep, diet, activity) and biomarker data (glucose, insulin levels) through our simple interface. Connect with your existing health apps and wearables for seamless data integration.

IRScore Dashboard

Get Your IRScore

Our AI algorithm processes your data to generate a personalized IRScore between 0-100, indicating your current insulin resistance risk level. The score updates in real-time as new data is logged.

Trajectory & Recommendations

Track Progress & Receive Recommendations

Monitor your IRScore trajectory over time and receive personalized recommendations to improve your metabolic health. Each suggestion includes a projected impact on your IRScore.

Competitive Advantage

Unlike competitors that rely on expensive and invasive methods for diabetes management such as CGMs, NexFlow provides real-time insulin resistance estimates using non-invasive lifestyle and biomarker data.

Feature Levels Signos January AI NexFlow
Real-Time IR Monitoring
Non-Invasive & Accessible
Predictive Lifestyle Modeling
Personalized Pathways

Market Opportunity

NexFlow addresses a massive and growing market of individuals at risk for metabolic disorders.

$20M
Target Market
$376M
Serviceable Addressable Market
$940M
Total Addressable Market

Our Team

Our team combines expertise in biomedical research, machine learning, and digital health product development to create actionable, real-time tools for metabolic wellness.

Join Our Waitlist

Be the first to know when NexFlow launches and get exclusive early access.

Diabetes FAQs

Answers to common questions about diabetes, insulin resistance, and metabolic health.

Insulin resistance happens when the body stops responding to insulin effectively, often years before Type 2 diabetes develops. NexFlow detects and tracks insulin resistance early—helping you take action before it becomes diabetes.

No—prediabetes means your blood sugar is higher than normal but not yet in the diabetes range. NexFlow helps reverse prediabetes by identifying early warning signs and providing actionable lifestyle guidance.

Diabetes is chronic high blood sugar; hypoglycemia is low blood sugar. While both involve blood sugar issues, they're opposite conditions. NexFlow helps detect patterns that may signal risk for either.

Yes. People with diabetes often have high blood pressure, which increases the risk of heart disease and stroke. NexFlow tracks metabolic health trends to help you manage both.

Early symptoms include fatigue, frequent urination, increased thirst, and blurry vision. NexFlow helps differentiate these signs and guides you toward preventive steps if you're at risk.

NexFlow FAQs

Find answers to common questions about NexFlow's platform, integrations, and partnerships.

NexFlow is an AI-powered platform that provides real-time, personalized insights into insulin resistance and metabolic health. By integrating lifestyle, biomarker, and device data, NexFlow delivers actionable recommendations and risk scores to help users and organizations manage diabetes proactively.

NexFlow is designed for individuals at risk for diabetes, healthcare providers, clinics, and organizations seeking to improve metabolic health outcomes through advanced analytics and seamless integrations.

NexFlow supports integration with EHR systems, medical devices (such as CGMs), lab services, and third-party health apps via secure APIs and custom solutions.

Yes. NexFlow uses industry-standard encryption and follows best practices for data privacy and security, ensuring all user and partner data is protected.

Visit the Collaborate page or contact us directly to discuss partnership opportunities, integration options, and custom solutions for your organization.